Volume : 13, Issue : 01, January – 2026
Title:
FORMULATION DEVELOPMENT AND EVALUATION OF RESVERATROL LOADED METAL OXIDE NANOPARTICLES
Authors :
Pankaj Singh*, Shradha Shende, Vaishali Rathi
Abstract :
The present investigation focused on the synthesis, characterization, and evaluation of Resveratrol-loaded copper oxide nanoparticles (CuO-NPs). Resveratrol, identified as an off-white, bitter, amorphous solid, exhibited a melting point of 259–260 °C and demonstrated solubility in phosphate buffer (pH 6.8), 0.1N HCl, methanol, and ethanol, with limited solubility in water. Its partition coefficient (Log P = 8.875) indicated moderate lipophilicity, and UV spectroscopic analysis revealed a maximum absorption wavelength at 304 nm. A calibration curve prepared in phosphate buffer (pH 6.8) showed linearity in the range of 10–50 µg/ml with a correlation coefficient of 0.995. Compatibility studies confirmed suitability of selected excipients for nanoparticle formulation. Five formulations (DCN-1 to DCN-5) of Resveratrol-loaded CuO-NPs were synthesized using varying drug-to-copper nitrate ratios, with optimized stirring conditions of 800 rpm for 3 hours. The percentage yield ranged between 58.21–66.71%. Particle size analysis revealed nanoparticles in the range of 90 ± 9 to 142 ± 16 nm with polydispersity indices of 0.198–0.247 and zeta potential values below –3.05, indicating stability. Drug entrapment efficiencies varied from 29.38–48.28%, decreasing at extreme copper nitrate concentrations. SEM analysis of the optimized formulation (DCN-3) confirmed irregular surface morphology. In-vitro drug release studies demonstrated that DCN-3 exhibited the highest release (93.42%), and kinetic modeling suggested that the release mechanism followed the Peppas–Korsmeyer model, indicating diffusion-controlled kinetics with possible polymer relaxation or erosion. Overall, the study highlights the potential of CuO-NPs as a promising carrier system for enhancing the bioavailability and controlled release of Resveratrol.
Keywords: Nanocarrier, Copper Oxide, Resveratrol, Metal Oxide, Nanoparticles, Natural
Cite This Article:
Please cite this article in press Pankaj Singh et al., Formulation Development And Evaluation Of Resveratrol Loaded Metal Oxide Nanoparticles, Indo Am. J. P. Sci, 2026; 13(01).
REFERENCES:
1. Mangesh Pede, Shivprasad Deokar, Dr. Rajendra kawade, Nanotechnology In Medicine: A Comprehensive Review Of Current Applications And Future Perspectives, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 12, 136-146.
2. Ramos-Zúñiga J. Bruna N. Pérez-Donoso J.M. Toxicity mechanisms of copper nanoparticles and Copper Surfaces on Bacterial Cells and Viruses. Int. J. Mol. Sci. 2023, 24, 10503.
3. Ali M, Benfante V, Di Raimondo D, Salvaggio G, Tuttolomondo A, Comelli A. Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent. Pharmaceuticals. 2024; 17(1):126.
4. Emima Jeronsia, J.; Allwin Joseph, L.; Annie Vinosha, P.; Jerline Mary, A.; Jerome Das, S. Camellia Sinensis Leaf Extract Mediated Synthesis of Copper Oxide Nanostructures for Potential Biomedical Applications. In Materials Today: Proceedings; Elsevier Ltd, 2019; pp. 214–222.
5. Ruiz, L.M.; Libedinsky, A.; Elorza, A.A. Role of Copper on Mitochondrial Function and Metabolism. Front. Mol. Biosci. 2021, 8, 711227.
6. Grigore, M.E, Biscu, E.R, Holban, A.M, Gestal, M.C., Grumezescu, A.M. Methods of synthesis, propertiesand biomedical of CuO applications nanoparticles. Pharmaceuticals 2016;9:75.
7. Grasso, G.; Zane, D.; Dragone, R. Microbial nanotechnology: Challenges and prospects for green biocatalytic synthesis of nanoscale materials for sensoristic and biomedical applications. Nanomaterials 2020, 10.
8. Naz, S., Gul, A., Zia, M. et al. Synthesis, biomedical applications, and toxicity of CuO nanoparticles. Appl Microbiol Biotechnol 107, 1039–1061 (2023).
9. Zheng, Y., Jia, R., Li, J. et al. Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma. J Nanobiotechnol 20, 339 (2022).
10. Gulati, K.; Chopra, D.; Kocak-Oztug, N.A.; Verron, E. Fit and forget: The future of dental implant therapy via nanotechnology. Adv. Drug Deliv. Rev. 2023, 199, 114900.